CA2307905A1 - 3-aminoalkylamino- 2h-1,4-benzoxazines et 3-aminoalkylamino- 2h-1,4-benzothiazines constituant des ligands specifiques d'un sous-type de recepteur de la dopamine - Google Patents

3-aminoalkylamino- 2h-1,4-benzoxazines et 3-aminoalkylamino- 2h-1,4-benzothiazines constituant des ligands specifiques d'un sous-type de recepteur de la dopamine Download PDF

Info

Publication number
CA2307905A1
CA2307905A1 CA002307905A CA2307905A CA2307905A1 CA 2307905 A1 CA2307905 A1 CA 2307905A1 CA 002307905 A CA002307905 A CA 002307905A CA 2307905 A CA2307905 A CA 2307905A CA 2307905 A1 CA2307905 A1 CA 2307905A1
Authority
CA
Canada
Prior art keywords
alkyl
compound according
nitrogen
hydrogen
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002307905A
Other languages
English (en)
Inventor
Xiao-Shu He
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurogen Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2307905A1 publication Critical patent/CA2307905A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

La présente invention concerne des composés représentés par la formule générale (I) ou certains de leurs sels d'addition acides pharmaceutiquement admis. En l'occurrence, Ar est aryle ou hétéroaryle. R¿1? et R¿2?, qui sont identiques ou différents, sont des substituants organiques ou inorganiques. R¿5? est hydrogène ou C¿1?-C¿6? alkyle. W est CH ou azote. X est oxygène ou soufre. Enfin, A est un groupe alkylène. Se liant sélectivement avec une affinité élevée au récepteur de sous-type D¿4? de la dopamine, ces composés conviennent particulièrement au traitement de divers troubles neurophychologiques.
CA002307905A 1997-10-31 1998-10-28 3-aminoalkylamino- 2h-1,4-benzoxazines et 3-aminoalkylamino- 2h-1,4-benzothiazines constituant des ligands specifiques d'un sous-type de recepteur de la dopamine Abandoned CA2307905A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96202297A 1997-10-31 1997-10-31
US08/962,022 1997-10-31
PCT/US1998/022936 WO1999023092A2 (fr) 1997-10-31 1998-10-28 3-aminoalkylamino- 2h-1,4-benzoxazines et 3-aminoalkylamino- 2h-1,4-benzothiazines constituant des ligands specifiques d'un sous-type de recepteur de la dopamine

Publications (1)

Publication Number Publication Date
CA2307905A1 true CA2307905A1 (fr) 1999-05-14

Family

ID=25505330

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002307905A Abandoned CA2307905A1 (fr) 1997-10-31 1998-10-28 3-aminoalkylamino- 2h-1,4-benzoxazines et 3-aminoalkylamino- 2h-1,4-benzothiazines constituant des ligands specifiques d'un sous-type de recepteur de la dopamine

Country Status (5)

Country Link
EP (1) EP1027347A2 (fr)
JP (1) JP2001521935A (fr)
AU (1) AU1286399A (fr)
CA (1) CA2307905A1 (fr)
WO (1) WO1999023092A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100255A (en) * 1998-10-28 2000-08-08 Neurogen Corporation 3-aminoalkylamino-2H-1,4-benzoxazines and 3-aminoalkylamino-2H-1,4-benzothiazines: dopamine receptor subtype specific ligands
US6084098A (en) 1999-02-26 2000-07-04 Neurogen Corporation Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands
WO1999043670A1 (fr) * 1998-02-26 1999-09-02 Neurogen Corporation Derives de benzylpiperazinyl et piperidinyl ethanone, preparation, et utilisation comme antagonistes des recepteurs d4 de la dopamine
CN1325397A (zh) * 1998-09-30 2001-12-05 纽罗根公司 2－哌嗪烷基氨基苯并吡咯衍生物∶多巴胺受体亚型特异配体
US6284759B1 (en) 1998-09-30 2001-09-04 Neurogen Corporation 2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands
DE19941115A1 (de) * 1999-08-25 2001-03-01 Schering Ag Neue Benzoxazin- und Bezothiazin-Derivate und deren Verwendung in Arzneimitteln
EP1177792A3 (fr) 2000-07-27 2002-10-23 Pfizer Products Inc. Ligands dopamine d4 destines au traitement des troubles associees a la cherche de la nouveaute
US8411271B2 (en) 2005-12-28 2013-04-02 Nikon Corporation Pattern forming method, pattern forming apparatus, and device manufacturing method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0186310A1 (fr) * 1984-11-28 1986-07-02 Takeda Chemical Industries, Ltd. Dérivés de 1,4-benzothiazine, leurs préparation et application

Also Published As

Publication number Publication date
AU1286399A (en) 1999-05-24
EP1027347A2 (fr) 2000-08-16
WO1999023092A3 (fr) 1999-08-05
WO1999023092A2 (fr) 1999-05-14
JP2001521935A (ja) 2001-11-13

Similar Documents

Publication Publication Date Title
US6444819B1 (en) Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands
EP0873329B1 (fr) Nouveaux n-aminoalkylfluorenecarboxamides; nouvelle classe de ligands specifiques de sous-types de recepteurs dopaminergiques
EP0891354B1 (fr) N-aminoalkyldibenzofurancarboxamides utilises comme ligands specifiques du sous-type du recepteur de la dopamine
US5892041A (en) Fused indolecarboxamides: dopamine receptor subtype specific ligands
WO1998006717A9 (fr) Indolecarboxamides fondus: ligands specifiques des sous-types de recepteur de la dopamine
CA2251989A1 (fr) Aminoalkylcarboxamides tricycliques, nouveaux ligands specifiques a des sous-types de recepteurs de la dopamine d3
AU6280199A (en) 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands
WO1999043670A1 (fr) Derives de benzylpiperazinyl et piperidinyl ethanone, preparation, et utilisation comme antagonistes des recepteurs d4 de la dopamine
CA2307905A1 (fr) 3-aminoalkylamino- 2h-1,4-benzoxazines et 3-aminoalkylamino- 2h-1,4-benzothiazines constituant des ligands specifiques d'un sous-type de recepteur de la dopamine
US6432946B1 (en) 3-aminoalkylamino-2H-1,4-benzoxazines and 3-aminoalkylamino-2H-1,4-benzothiazines: dopamine receptor subtype specific ligands
US5703237A (en) N-Aminoalkyl-2-anthraquinonecarboxamides; new dopamine receptor subtype specific ligands
EP0898567B1 (fr) N-aminoalkyl-1-biphenylenyl-2-carboxamides; ligands specifiques de sous-types de recepteurs de la dopamine
EP0888320A1 (fr) Nouveaux n-aminoalkyl-2-anthracenecarboxamides; nouveaux ligands specifiques de sous-type de recepteur de dopamine
WO1999064396A1 (fr) 1-aryl-3-benzylaminopyrrolidine substitue: ligands specifiques aux sous-types des recepteurs de dopamine
CA2293480A1 (fr) 2-aminoalkylaminoquinoleines utilisees comme ligands de la dopamine d4
US6166205A (en) 2-Aryl-4-(1-[4-heteroaryl]piperazin-1-yl)methylimidazoles: dopamine . D.sub4 receptor subtype ligands
WO2000012500A2 (fr) 2-aryl-4-[4-heteroaryl]piperazin-1-yl methylimidazoles: ligands pour le sous-type de recepteur d4 de la dopamine
MXPA99008086A (en) 1-(isoquinolin-1-yl)-4-(1-phenylmethyl)piperazines;dopamine receptor subtype specific ligands
MXPA98008541A (en) N-aminoalquil-2-antraquinoncarboxamidas; new specific ligands of the dopam receiver subtype
MXPA99001574A (en) Fused indolecarboxamides:dopamine receptor subtype specific ligands

Legal Events

Date Code Title Description
FZDE Dead